サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1675291

呼吸器診断市場：製品・サービスタイプ別、検査タイプ別、疾患別、エンドユーザー別、地域別、2025-2033年

Respiratory Diagnostics Market Report by Product and Service Type, Test Type, Disease, End-User, and Region 2025-2033

出版日
発行
IMARC
ページ情報
英文 135 Pages
納期
2～3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.99円
呼吸器診断市場：製品・サービスタイプ別、検査タイプ別、疾患別、エンドユーザー別、地域別、2025-2033年
出版日: 2025年03月01日
発行: IMARC
ページ情報: 英文 135 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

呼吸器診断市場の世界市場規模は2024年に86億米ドルに達しました。今後、IMARC Groupは、市場は2033年までに155億米ドルに達し、2025～2033年の成長率（CAGR）は6.43％になると予測しています。呼吸器疾患の有病率の増加、ヘルスケア支出の増加、高齢化人口の増加、患者の転帰を改善し慢性疾患を効果的に管理するための早期かつ正確な診断に対する需要の高まりが、市場成長を促す要因の一部です。

呼吸器診断とは、肺の機能と関連するプロセスを臨床的に評価することです。喘息、慢性閉塞性肺疾患（COPD）、肺がん、気管支炎、肺線維症などを検出するための機械的、画像的、分子的診断検査が含まれます。スパイロメトリー、オキシメトリー、経皮的CO2モニタリング、鼻腔吸気圧（SNIP）、胸部X線検査、コンピュータ断層撮影（CT）スキャンなどの検査を行う。場合によっては、睡眠時無呼吸症候群や夜間低換気の有無を診断・評価するために睡眠検査も行われます。

呼吸器疾患の有病率の増加は、市場の成長を促す主な要因の一つです。喫煙者の増加やアルコールの消費、座りがちな生活習慣やストレスの多い日常生活などが、COPDや肺がんなどの重篤な呼吸器疾患の発生率の上昇につながっています。さらに、COPDの診断や外来患者の管理にモノのインターネット（IoT）や人工知能（AI）を活用するなど、呼吸器診断検査におけるさまざまな技術革新が市場成長に好影響を与えています。また、さまざまな民間病院やヘルスケアセンターにおける呼吸器診断装置の需要の増加や、質の高いヘルスケア施設を誰もが利用できるようにするための政府と非政府組織（NGO）の両者の取り組みが、呼吸器診断装置市場を牽引しています。その他の市場開拓要因としては、研究開発（R&D）の強化、老人人口の増加、急速な都市化と工業施設の増加、世界の汚染レベルの上昇などが挙げられます。

本レポートで扱う主な質問

  • 世界市場はこれまでどのように推移し、今後数年間はどのように推移するのか？
  • 世界市場における市場促進要因、抑制要因、最近のビジネスチャンスは何か？
  • それぞれの促進要因、抑制要因、機会が世界市場に与える影響は？
  • 主要な地域市場とは？
  • 最も魅力的な市場はどの国か？
  • 製品・サービスタイプ別の市場内訳は？
  • 市場で最も魅力的な製品・サービスタイプは？
  • 検査タイプ別の市場内訳は？
  • 市場で最も魅力的な検査タイプは？
  • 疾患別の市場内訳は？
  • 市場で最も魅力的な疾患は？
  • エンドユーザー別の市場内訳は？
  • 市場で最も魅力的なエンドユーザーは？
  • 市場の競合構造は？
  • 世界市場における主要プレイヤー/企業は？

目次

第1章 序文

第2章 調査範囲と調査手法

  • 調査の目的
  • ステークホルダー
  • データソース
    • 一次情報
    • 二次情報
  • 市場推定
    • ボトムアップアプローチ
    • トップダウンアプローチ
  • 調査手法

第3章 エグゼクティブサマリー

第4章 イントロダクション

  • 概要
  • 主要業界動向

第5章 世界の呼吸器診断市場

  • 市場概要
  • 市場実績
  • COVID-19の影響
  • 市場内訳：製品・サービスタイプ別
  • 市場内訳：検査タイプ別
  • 市場内訳：疾患別
  • 市場内訳：エンドユーザー別
  • 市場内訳：地域別
  • 市場予測

第6章 市場内訳：製品・サービスタイプ別

  • 機器とサービス
  • アッセイおよび試薬
  • サービスとソフトウェア

第7章 市場内訳：検査タイプ別

  • 機械試験
  • 閉塞性睡眠時無呼吸（OSA）診断検査
  • 画像検査
  • 従来の診断検査
  • 分子診断検査
  • その他

第8章 市場内訳：疾患別

  • 結核
  • 喘息
  • 慢性閉塞性肺疾患（COPD）
  • 肺がん
  • その他

第9章 市場内訳：エンドユーザー別

  • 病院
  • クリニック
  • 臨床検査室
  • その他

第10章 市場内訳：地域別

  • 北米
  • 欧州
  • アジア太平洋地域
  • 中東・アフリカ
  • ラテンアメリカ

第11章 SWOT分析

  • 概要
  • 強み
  • 弱み
  • 機会
  • 脅威

第12章 バリューチェーン分析

第13章 ポーターのファイブフォース分析

  • 概要
  • 買い手の交渉力
  • 供給企業の交渉力
  • 競合の程度
  • 新規参入業者の脅威
  • 代替品の脅威

第14章 競合情勢

  • 市場構造
  • 主要企業
  • 主要企業のプロファイル
    • Philips Healthcare
    • Abbott Laboratories
    • Biomerieux
    • Becton Dickinson
    • Thermo Fisher Scientific Inc.
    • Alere Inc.
    • Seegene Inc.
    • 3M
    • Bio-Rad Laboratories Inc.
    • SDI Diagnostics
    • COSMED
図表

List of Figures

  • Figure 1: Global: Respiratory Diagnostics Market: Major Drivers and Challenges
  • Figure 2: Global: Respiratory Diagnostics Market: Sales Value (in Billion USD), 2019-2024
  • Figure 3: Global: Respiratory Diagnostics Market: Breakup by Product and Service Type (in %), 2024
  • Figure 4: Global: Respiratory Diagnostics Market: Breakup by Test Type (in %), 2024
  • Figure 5: Global: Respiratory Diagnostics Market: Breakup by Disease (in %), 2024
  • Figure 6: Global: Respiratory Diagnostics Market: Breakup by End User (in %), 2024
  • Figure 7: Global: Respiratory Diagnostics Market: Breakup by Region (in %), 2024
  • Figure 8: Global: Respiratory Diagnostics Market Forecast: Sales Value (in Billion USD), 2025-2033
  • Figure 9: Global: Respiratory Diagnostics Industry: SWOT Analysis
  • Figure 10: Global: Respiratory Diagnostics Industry: Value Chain Analysis
  • Figure 11: Global: Respiratory Diagnostics Industry: Porter's Five Forces Analysis
  • Figure 12: Global: Respiratory Diagnostics (Instruments and Services) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 13: Global: Respiratory Diagnostics (Instruments and Services) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 14: Global: Respiratory Diagnostics (Assays and Reagents) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 15: Global: Respiratory Diagnostics (Assays and Reagents) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 16: Global: Respiratory Diagnostics (Services and Software) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 17: Global: Respiratory Diagnostics (Services and Software) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 18: Global: Respiratory Diagnostics (Mechanical Tests) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 19: Global: Respiratory Diagnostics (Mechanical Tests) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 20: Global: Respiratory Diagnostics (Obstructive Sleep Apnoea Diagnostic Tests) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 21: Global: Respiratory Diagnostics (Obstructive Sleep Apnoea Diagnostic Tests) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 22: Global: Respiratory Diagnostics (Imaging Tests) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 23: Global: Respiratory Diagnostics (Imaging Tests) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 24: Global: Respiratory Diagnostics (Traditional Diagnostic Tests) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 25: Global: Respiratory Diagnostics (Traditional Diagnostic Tests) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 26: Global: Respiratory Diagnostics (Molecular Diagnostic Tests) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 27: Global: Respiratory Diagnostics (Molecular Diagnostic Tests) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 28: Global: Respiratory Diagnostics (Other Test Types) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 29: Global: Respiratory Diagnostics (Other Test Types) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 30: Global: Respiratory Diagnostics (Tuberculosis) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 31: Global: Respiratory Diagnostics (Tuberculosis) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 32: Global: Respiratory Diagnostics (Asthma) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 33: Global: Respiratory Diagnostics (Asthma) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 34: Global: Respiratory Diagnostics (Chronic Obstructive Pulmonary Disease) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 35: Global: Respiratory Diagnostics (Chronic Obstructive Pulmonary Disease) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 36: Global: Respiratory Diagnostics (Lung Cancer) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 37: Global: Respiratory Diagnostics (Lung Cancer) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 38: Global: Respiratory Diagnostics (Other Disease Types) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 39: Global: Respiratory Diagnostics (Other Disease Types) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 40: Global: Respiratory Diagnostics (Hospitals) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 41: Global: Respiratory Diagnostics (Hospitals) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 42: Global: Respiratory Diagnostics (Clinics) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 43: Global: Respiratory Diagnostics (Clinics) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 44: Global: Respiratory Diagnostics (Reference and Clinical Laboratories) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 45: Global: Respiratory Diagnostics (Reference and Clinical Laboratories) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 46: Global: Respiratory Diagnostics (Other End-Users) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 47: Global: Respiratory Diagnostics (Other End-Users) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 48: North America: Respiratory Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 49: North America: Respiratory Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 50: Europe: Respiratory Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 51: Europe: Respiratory Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 52: Asia Pacific: Respiratory Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 53: Asia Pacific: Respiratory Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 54: Middle East and Africa: Respiratory Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 55: Middle East and Africa: Respiratory Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 56: Latin America: Respiratory Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 57: Latin America: Respiratory Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033

List of Tables

  • Table 1: Global: Respiratory Diagnostics Market: Key Industry Highlights, 2024 and 2033
  • Table 2: Global: Respiratory Diagnostics Market Forecast: Breakup by Product and Service Type (in Million USD), 2025-2033
  • Table 3: Global: Respiratory Diagnostics Market Forecast: Breakup by Test Type (in Million USD), 2025-2033
  • Table 4: Global: Respiratory Diagnostics Market Forecast: Breakup by Disease (in Million USD), 2025-2033
  • Table 5: Global: Respiratory Diagnostics Market Forecast: Breakup by End-User (in Million USD), 2025-2033
  • Table 6: Global: Respiratory Diagnostics Market Forecast: Breakup by Region (in Million USD), 2025-2033
  • Table 7: Global: Respiratory Diagnostics Market Structure
  • Table 8: Global: Respiratory Diagnostics Market: Key Players
目次
Product Code: SR112025A1620

The global respiratory diagnostics market size reached USD 8.6 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 15.5 Billion by 2033, exhibiting a growth rate (CAGR) of 6.43% during 2025-2033. The growing prevalence of respiratory diseases, rising healthcare expenditure, increasing aging population, and heightened demand for early and accurate diagnosis to improve patient outcomes and manage chronic conditions effectively are some of the factors impelling the market growth.

Respiratory diagnostics refer to the clinical assessment of lung functioning and related processes. It includes several mechanical, imaging and molecular diagnostic tests for detecting asthma, chronic obstructive pulmonary disease (COPD), lung cancer, bronchitis, and pulmonary fibrosis. It uses procedures, such as spirometry, oximetry, transcutaneous CO2 monitoring, sniff nasal inspiratory pressure (SNIP), chest X-ray and computed tomography (CT) scan. In some instances, sleep studies are also conducted to diagnose and assess the presence of sleep apnea and nocturnal hypoventilation.

The growing prevalence of respiratory diseases is one of the key factors driving the growth of the market. The increasing number of smokers and consumption of alcohol, coupled with sedentary lifestyle habits and stressful routines, have resulted in rising incidences of COPD and other severe respiratory conditions, such as lung cancer. Furthermore, various technological innovations in respiratory diagnostic testing, including the utilization of Internet of Things (IoT) and Artificial Intelligence (AI) for the diagnosis of COPD and outpatient management, are creating a positive impact on the market growth. Also, an increase in the demand for respiratory diagnostics devices in various privately-owned hospitals and healthcare centers and efforts by both government and non-governmental organizations (NGO) to make quality healthcare facilities accessible to all are driving the market for respiratory diagnostics. Other factors contributing to the market growth include enhanced research and development (R&D), rising geriatric population, rapid urbanization and increasing industrial establishments, and growing pollution levels across the globe.

Key Market Segmentation:

Breakup by Product and Service Type:

  • Instruments and Services
  • Assays and Reagents
  • Services and Software

Breakup by Test Type:

  • Mechanical Tests
  • Obstructive Sleep Apnoea (OSA) Diagnostic Tests
  • Imaging Tests
  • Traditional Diagnostic Tests
  • Molecular Diagnostic Tests
  • Others

Breakup by Disease:

  • Tuberculosis
  • Asthma
  • Chronic Obstructive Pulmonary Disease (COPD)
  • Lung Cancer
  • Others

Breakup by End-User:

  • Hospitals
  • Clinics
  • Reference and Clinical Laboratories
  • Others

Breakup by Region:

  • North America
  • Europe
  • Asia Pacific
  • Middle East and Africa
  • Latin America

Competitive Landscape:

The report has also analyzed the competitive landscape of the market with some of the key players being Philips Healthcare, Abbott Laboratories, Biomerieux, Becton Dickinson, Thermo Fisher Scientific Inc., Alere Inc., Seegene Inc., 3M, Bio-Rad Laboratories, SDI Diagnostics and COSMED.

Key Questions Answered in This Report:

  • How has the global market performed so far, and how will it perform in the coming years?
  • What are the drivers, restraints, and respiratory diagnostics market recent opportunities in the global market?
  • What is the impact of each driver, restraint, and opportunity on the global market?
  • What are the key regional markets?
  • Which countries represent the most attractive market?
  • What is the breakup of the market based on the product and service type?
  • Which is the most attractive product and service type in the market?
  • What is the breakup of the market based on the test type?
  • Which is the most attractive test type in the market?
  • What is the breakup of the market based on the disease?
  • Which is the most attractive disease in the market?
  • What is the breakup of the market based on the end-user?
  • Which is the most attractive end-user in the market?
  • What is the competitive structure of the market?
  • Who are the key players/companies in the global market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Respiratory Diagnostics Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Breakup by Product and Service Type
  • 5.5 Market Breakup by Test Type
  • 5.6 Market Breakup by Disease
  • 5.7 Market Breakup by End-User
  • 5.8 Market Breakup by Region
  • 5.9 Market Forecast

6 Market Breakup by Product and Service Type

  • 6.1 Instruments and Services
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Assays and Reagents
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Services and Software
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast

7 Market Breakup by Test Type

  • 7.1 Mechanical Tests
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Obstructive Sleep Apnoea (OSA) Diagnostic Tests
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Imaging Tests
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Traditional Diagnostic Tests
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 Molecular Diagnostic Tests
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast
  • 7.6 Others
    • 7.6.1 Market Trends
    • 7.6.2 Market Forecast

8 Market Breakup by Disease

  • 8.1 Tuberculosis
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Asthma
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Chronic Obstructive Pulmonary Disease (COPD)
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Lung Cancer
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast
  • 8.5 Others
    • 8.5.1 Market Trends
    • 8.5.2 Market Forecast

9 Market Breakup by End User

  • 9.1 Hospitals
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Clinics
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Reference and Clinical Laboratories
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast
  • 9.4 Others
    • 9.4.1 Market Trends
    • 9.4.2 Market Forecast

10 Market Breakup by Region

  • 10.1 North America
    • 10.1.1 Market Trends
    • 10.1.2 Market Forecast
  • 10.2 Europe
    • 10.2.1 Market Trends
    • 10.2.2 Market Forecast
  • 10.3 Asia Pacific
    • 10.3.1 Market Trends
    • 10.3.2 Market Forecast
  • 10.4 Middle East and Africa
    • 10.4.1 Market Trends
    • 10.4.2 Market Forecast
  • 10.5 Latin America
    • 10.5.1 Market Trends
    • 10.5.2 Market Forecast

11 SWOT Analysis

  • 11.1 Overview
  • 11.2 Strengths
  • 11.3 Weaknesses
  • 11.4 Opportunities
  • 11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

  • 13.1 Overview
  • 13.2 Bargaining Power of Buyers
  • 13.3 Bargaining Power of Suppliers
  • 13.4 Degree of Competition
  • 13.5 Threat of New Entrants
  • 13.6 Threat of Substitutes

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Philips Healthcare
    • 14.3.2 Abbott Laboratories
    • 14.3.3 Biomerieux
    • 14.3.4 Becton Dickinson
    • 14.3.5 Thermo Fisher Scientific Inc.
    • 14.3.6 Alere Inc.
    • 14.3.7 Seegene Inc.
    • 14.3.8 3M
    • 14.3.9 Bio-Rad Laboratories Inc.
    • 14.3.10 SDI Diagnostics
    • 14.3.11 COSMED